Current Price | $4.84 | Mkt Cap | $395.8M |
---|---|---|---|
Open | $4.85 | P/E Ratio | -9.00 |
Prev. Close | $4.82 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.80 - $4.91 | Volume | 124,409 |
52-Wk Range | $4.80 - $10.45 | Avg. Daily Vol. | 1,577,406 |
Current Price | $4.84 | Mkt Cap | $395.8M |
---|---|---|---|
Open | $4.85 | P/E Ratio | -9.00 |
Prev. Close | $4.82 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.80 - $4.91 | Volume | 124,409 |
52-Wk Range | $4.80 - $10.45 | Avg. Daily Vol. | 1,577,406 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell… More
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Read the most recent pitches from players about AVXL.
Recs
Bad profit ratios
Recs
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell after they reported positive Phase I results for another candidate in their pipeline (3-71); Investors are too quick to fold their hands; They forget that she is close to completing Phase III testing for her flagship candidate 2-73; 100% of trial study patients have voluntarily signed up for continued treatment under extended long term study protocols since Phase I; Study goals exceed required FDA data points; They’ve also received positive feedback from preliminary FDA reviews with zero change recommendations offered; I predict full FDA approval before year's end; Stock likely to move long before then regardless of what the general market is doing
Recs
Shrinking deficit and improving technicals.
Find the members with the highest scoring picks in AVXL.
DorminABC (99.48) Score: +369.22
The Score Leader is the player with the highest score across all their picks in AVXL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
DorminABC | 99.48 | 3/17/2011 | NS | $15.28 | -68.46% | +300.77% | +369.22 | 0 Comment | ||
whatisthepoint | 91.44 | 10/12/2015 | 5Y | $9.52 | -49.37% | +155.12% | +204.49 | 0 Comment | ||
Theige | 28.58 | 10/12/2015 | 5Y | $8.30 | -41.93% | +154.62% | +196.55 | 0 Comment | ||
FSaucy | 90.72 | 10/6/2015 | NS | $6.12 | -21.24% | +159.75% | +181.00 | 0 Comment | ||
MMCapitalMgmt | 95.82 | 10/23/2015 | 5Y | $7.18 | -32.87% | +147.36% | +180.23 | 0 Comment | ||
jed71 | 42.72 |
|
5Y | $5.20 | -7.31% | +164.39% | +171.70 | 0 Comment | ||
TinyCapsWatch | 98.55 | 7/5/2016 | 5Y | $5.80 | -16.90% | +145.45% | +162.34 | 0 Comment | ||
fps32 | 75.22 | 9/3/2015 | 5Y | $4.84 | -0.41% | +161.32% | +161.73 | 0 Comment | ||
zzlangerhans | 98.50 | 2/18/2016 | 1Y | $4.27 | +12.88% | +167.07% | +154.19 | 1 Comment | ||
JoeySolitro3 | 99.24 | 2/18/2016 | 5Y | $4.13 | +16.71% | +167.30% | +150.59 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.